Taysha Gene Therapies, Inc.

Nasdaq:TSHA

Biological Products, (No Diagnostic Substances)·DALLAS, TX

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	2/26/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
11/4/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
2/26/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
↓

News (8-K)

57 shown

Filed	Type	Description
10/16/25	Other	Other Events	→
10/9/25	Other	Other Events	→
10/2/25	Other	Other Events	→
6/3/25	Vote	Amendments to Articles of Incorporation or Bylaws	→
5/29/25	Agreement	Entry into a Material Definitive Agreement	→
5/29/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

32 shown

Filed	Form	Description
1/6/26	S-8	S-8	→
11/4/25	S-3ASR	S-3ASR	→
5/29/25	424B5	424B5	→
5/28/25	424B5	424B5	→
4/21/25	ARS	ARS	→
1/7/25	S-8	S-8	→
↓

Filing History(375 filings)

TypeDateAccessionPeriodSize

144

Feb 27, 2026

0002086827-26-000008

—

6.9 KB

SCHEDULE 13G

Feb 17, 2026

0000902664-26-001081

—

14.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001493215-26-000050

—

10.5 KB

Feb 6, 2026

0001793412-26-000012

Feb 4, 2026

4.8 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000536

—

11.2 KB

144

Feb 4, 2026

0001977343-26-000005

—

6.3 KB

144

Feb 4, 2026

0001979666-26-000006

—

6.3 KB

144

Feb 4, 2026

0001979693-26-000007

—

6.3 KB

144

Feb 4, 2026

0002086827-26-000006

—

6.2 KB

144

Feb 4, 2026

0001793412-26-000010

—

6.1 KB

Jan 27, 2026

0001665124-26-000008

Jan 23, 2026

7.1 KB

Jan 27, 2026

0001569926-26-000008

Jan 23, 2026

8.0 KB

Jan 27, 2026

0001793412-26-000008

Jan 23, 2026

7.0 KB

144

Jan 23, 2026

0001569926-26-000006

—

4.7 KB

144

Jan 23, 2026

0001665124-26-000006

—

6.1 KB

144

Jan 23, 2026

0002086827-26-000004

—

4.7 KB

144

Jan 23, 2026

0001979666-26-000004

—

4.8 KB

144

Jan 23, 2026

0001977343-26-000003

—

4.8 KB

144

Jan 23, 2026

0001979693-26-000005

—

4.8 KB

144

Jan 23, 2026

0001793412-26-000006

—

4.6 KB

SCHEDULE 13G/A

Jan 21, 2026

0002012383-26-000794

—

10.7 KB

Jan 14, 2026

0001793412-26-000002

Jan 12, 2026

7.2 KB

Jan 14, 2026

0001569926-26-000002

Jan 12, 2026

8.2 KB

Jan 14, 2026

0001665124-26-000002

Jan 12, 2026

17.0 KB

144

Jan 12, 2026

0001974158-26-000011

—

6.3 KB

25 filings shown

Filed	Form	Description
5/9/25	DEFR14A	DEFR14A	→
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEF 14A	DEF 14A	→
4/10/25	PRE 14A	PRE 14A	→
4/18/24	DEFA14A	DEFA14A	→
4/18/24	DEF 14A	DEF 14A	→
↓

Taysha Gene Therapies, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(375 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/6/26	4	4	→
1/27/26	4	4	→
1/27/26	4	4	→
1/27/26	4	4	→
1/14/26	4	4	→
1/14/26	4	4	→
↓

Filed	Form	Description
2/27/26	144	144	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/4/26	144	144	→
2/4/26	144	144	→
↓